Skip to main content
Watch Insiders
INBX filings

Corporate insider profile

Jon Faiz Kayyem Filing Activity

Latest reported as Corporate insider of Inhibrx Biosciences, Inc. (INBX).

Purchase filings
3
Reported companies
1
Net open-market value
$1,567,580
Latest transaction
Sep 23, 2026

Affiliated corporations

Reported company relationships

INBXLatest reported

Inhibrx Biosciences, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 23, 2026Inhibrx Biosciences, Inc. (INBX)Corporate insiderOpen Market Purchase5,000$100.00$500,000
Sep 16, 2026Inhibrx Biosciences, Inc. (INBX)Corporate insiderOpen Market Purchase5,000$100.00$500,000
Sep 8, 2026Inhibrx Biosciences, Inc. (INBX)Corporate insiderOpen Market Purchase5,000$113.52$567,580